{"date":"2025-06-05","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6541-2025-06-05-2037-ds864w","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-06-05","time":"20:37:36","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-06-05 20:37，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-06-05-1923-h72gn6","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"19:23:35","subject":"本公司受邀參加先探投資週刊舉辦之「2025年生技投資論壇」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-06-05 19:23，「本公司受邀參加先探投資週刊舉辦之「2025年生技投資論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-05-1857-15pab7z","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-05","time":"18:57:14","subject":"本公司向泰國食品藥物管理局遞交研發中產品EG1206A(pertuzumab生物相似藥)第三期臨床試驗計畫書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-05 18:57，「本公司向泰國食品藥物管理局遞交研發中產品EG1206A(pertuzumab生物相似藥)第三期臨床試驗計畫書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-05-1856-bfdfci","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-05","time":"18:56:53","subject":"本公司研發中產品EG1206A(pertuzumab生物相似藥)，獲得喬治亞醫療和藥品活動管理機構同意進行第三期臨床試驗","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-05 18:56，「本公司研發中產品EG1206A(pertuzumab生物相似藥)，獲得喬治亞醫療和藥品活動管理機構同意進行第三期臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-05-1757-bqcdn9","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:57:30","subject":"公告本公司第二屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-05 17:57，「公告本公司第二屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-06-05-1756-dog1nl","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:56:31","subject":"公告本公司董事會通過蔡政憲先生續任董事長","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-06-05 17:56，「公告本公司董事會通過蔡政憲先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1708-3kijut","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:08:29","subject":"公告本公司TAH3311取得澳洲「ApixabanFilm Product and Uses Thereof」發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:08，「公告本公司TAH3311取得澳洲「ApixabanFilm Product and Uses Thereof」發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1706-1v8yxnu","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:06:40","subject":"公告本公司114年股東常會通過解除本公司新任董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:06，「公告本公司114年股東常會通過解除本公司新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1705-nuuhie","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:05:56","subject":"公告本公司薪資報酬委員會委員因董事全面改選任期屆滿及新任名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:05，「公告本公司薪資報酬委員會委員因董事全面改選任期屆滿及新任名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1705-9769qc","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:05:10","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:05，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-06-05-1703-ds864w","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:03:50","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-06-05 17:03，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1703-1e5cb69","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:03:31","subject":"公告本公司設置審計委員會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:03，「公告本公司設置審計委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1702-ds864w","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:02:46","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:02，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-05-1701-e280bm","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"17:01:47","subject":"公告本公司114年股東常會全面改選董事暨三分之一以上董事發生變動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-05 17:01，「公告本公司114年股東常會全面改選董事暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-06-05-1622-qmmwae","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"16:22:51","subject":"公告本公司董事會決議召開114年第一次股東臨時會相關事宜","clause":"第32款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-06-05 16:22，「公告本公司董事會決議召開114年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-06-05-1558-ds864w","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-06-05","time":"15:58:28","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-06-05 15:58，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-06-05-1539-hiebb2","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-06-05","time":"15:39:44","subject":"公告本公司114年股東會重要決議事項","clause":"第18款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-06-05 15:39，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1526-67rslk","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:26:21","subject":"公告本公司薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:26，「公告本公司薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1525-1qv4g4g","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:25:46","subject":"公告本公司第三屆審計委員會名單","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:25，「公告本公司第三屆審計委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1525-9769qc","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:25:18","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:25，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1524-1cluvbr","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:24:47","subject":"第六屆董事當選名單","clause":"第6款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:24，「第六屆董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1524-1xqu4f0","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:24:19","subject":"公告本公司114年股東常會決議解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:24，「公告本公司114年股東常會決議解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-06-05-1523-ds864w","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-06-05","time":"15:23:47","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-06-05 15:23，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-06-05-1428-1m59z4c","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-06-05","time":"14:28:48","subject":"本公司有價證券近期多次達公佈注意交易資訊標準故公告相關訊息，以利投資人區別瞭解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-06-05 14:28，「本公司有價證券近期多次達公佈注意交易資訊標準故公告相關訊息，以利投資人區別瞭解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-06-05-1422-mwrjbx","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-06-05","time":"14:22:27","subject":"公告本公司訂定113年現金股利除息基準日","clause":"第14款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-06-05 14:22，「公告本公司訂定113年現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-06-05-1336-ds864w","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-06-05","time":"13:36:07","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-05","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-06-05 13:36，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}